Table 1. Univariate analysis of baseline characteristics among patients with and without IBD who underwent CRC surgery: National Inpatient Sample 2008–2012.
Non-IBD CRC ( n =394,605) | IBD CRC ( n =3,242) | P value | UC ( n =1,902) | P value | CD ( n =1,340) | P value | |
---|---|---|---|---|---|---|---|
Age (mean, CI) | 67.82 (67.64, 68.01) | 61.33 (60.17, 62.48) | <0.0001 | 61.62 (60.14, 63.10) | <0.0001 | 60.91 (59.13, 62.70) | <0.0001 |
Sex | 0.0751 | 0.0048 | 0.5576 | ||||
Male | 197,489 (50.05%) | 1,731 (53.39%) | 1,085 (57.02%) | 646 (48.22%) | |||
Female | 197,116 (49.95%) | 1,511 (46.61%) | 817 (42.98%) | 694 (51.78%) | |||
Race | <0.0001 | 0.0058 | 0.0001 | ||||
White | 304,569 (77.18%) | 2,790 (86.06%) | 1,607 (84.47%) | 1,183 (88.33%) | |||
Black | 40,805 (10.34%) | 187 (5.77%) | 109 (5.74%) | 78 (5.81%) | |||
Hispanic | 26,179 (6.63%) | 140 (4.31%) | 99 (5.21%) | 41 (3.04%) | |||
Other | 23,052 (5.84%) | 125 (3.85%) | 87 (4.58%) | 38 (2.82%) | |||
Insurance | <0.0001 | <0.0001 | <0.0001 | ||||
Medicare | 226,264 (57.34%) | 1,309 (40.38%) | 764 (40.18%) | 545 (40.65%) | |||
Medicaid | 20,484 (5.19%) | 192 (5.91%) | 123 (6.46%) | 69 (5.13%) | |||
Private | 128,021 (32.44%) | 1,597 (49.28%) | 923 (48.54%) | 674 (50.33%) | |||
Other | 19,836 (5.03%) | 144 (4.44%) | 92 (4.83%) | 52 (3.88%) | |||
Income quartile a | <0.0001 | 0.0002 | <0.0001 | ||||
1 | 100,612 (25.50%) | 550 (16.96%) | 340 (17.87%) | 210 (15.66%) | |||
2 | 100,372 (25.44%) | 730 (22.51%) | 433 (22.75%) | 297 (22.16%) | |||
3 | 97,319 (24.66%) | 919 (28.34%) | 536 (28.20%) | 382 (28.53%) | |||
4 | 96,302 (24.40%) | 1,044 (32.20%) | 593 (31.18%) | 451 (33.64%) | |||
Elixhauser comorbidity | 0.0015 | 0.0233 | 0.0310 | ||||
<3 | 212,795 (53.93%) | 1,949 (60.13%) | 1,137 (59.77%) | 812 (60.65%) | |||
≥3 | 181,810 (46.07%) | 1,292 (39.87%) | 765 (40.23%) | 527 (39.35%) | |||
Hospital bed size b | 0.0011 | 0.0082 | 0.0712 | ||||
Small | 44,345 (11.24%) | 305 (9.40%) | 178 (9.35%) | 127 (9.47%) | |||
Medium | 95,707 (24.25%) | 607 (18.73%) | 351 (18.43%) | 256 (19.14%) | |||
Large | 254,553 (64.51%) | 2,330 (71.88%) | 1,374 (72.22%) | 956 (71.39%) | |||
Hospital type | <0.0001 | <0.001 | 0.0213 | ||||
Rural | 40,699 (10.31%) | 158 (4.86%) | 85 (4.48%) | 72 (5.40%) | |||
Urban non-teaching | 166,988 (42.32%) | 1,217 (37.54%) | 650 (34.18%) | 567 (42.30%) | |||
Urban teaching | 186,918 (47.37%) | 1,867 (57.60%) | 1,167 (61.34%) | 701 (52.30%) | |||
Hospital region | 0.0033 | 0.0068 | 0.2265 | ||||
Northeast | 87,938 (22.29%) | 850 (26.23%) | 505 (26.56%) | 345 (25.77%) | |||
Midwest | 73,744 (18.69%) | 670 (20.66%) | 386 (20.31%) | 283 (21.16%) | |||
South | 161,975 (41.05%) | 1,087 (33.54%) | 614 (32.30%) | 473 (35.29%) | |||
West | 70,948 (17.98%) | 634 (19.57%) | 396 (20.83%) | 238 (17.79%) | |||
Lymph node positivity | 0.0359 | 0.0373 | 0.4166 | ||||
No | 313,145 (79.36%) | 2,680 (82.68%) | 1,589 (83.55%) | 1,091 (81.44%) | |||
Yes | 81,460 (20.64%) | 561 (17.32%) | 313 (16.45%) | 249 (18.56%) | |||
Distant metastasis | 0.0121 | 0.0287 | 0.2342 | ||||
No | 337,748 (85.59%) | 2,880 (88.85%) | 1,702 (89.47%) | 1,178 (87.97%) | |||
Yes | 56,857 (14.41%) | 362 (11.15%) | 200 (10.53%) | 161 (12.03%) |
Abbreviations: CD, Crohn’s disease; CI, confidence interval; CRC, colorectal cancer; IBD, inflammatory bowel disease; UC, ulcerative colitis.
Income quartile 1 contains lowest earning households. The exact income ranges vary from year to year.
Hospital bed size is classified by number of beds, and also by hospital region and type. For example, a large hospital requires more than 450 beds if it is an urban teaching hospital in the Southern region, while a large rural hospital in the Southern region only requires 75 beds. For additional information, please see www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp.